There were 04 main board IPOs in February 2025 of Quality Power Electrical Equipments Limited, Hexaware Technologies Limited, AJAX Engineering Limited, and Dr. Agarwal’s Health Care Limited against 06 main board IPOs in January 2025. There were 06 SME IPOs in February 2025 as against 15 SME IPOs in January 2025.
IPO activity is witnessing a slowdown, largely as a result of the secondary market correction, especially in January & February, which negatively impacted the share prices of several listed companies. As a result, investors have shifted focus to their existing portfolios rather than exploring new listings.
Dr. Agarwal’s Health Care Limited:
|
About the Company |
Established in 2012, Dr Agarwal’s Health Care offers a comprehensive range of eye care services, including cataract and refractive surgeries, consultations, diagnoses, non-surgical treatments, and the sale of optical products, contact lenses, accessories, and eye care-related pharmaceutical items. With a hub-and-spoke model, Dr Agarwal’s operates 26 tertiary facilities, 139 spokes, 3 centres of excellence across India & 16 facilities across 9 African countries. The revenue increased from Rs 1018 Crores in FY23 to Rs 1332 Crores in FY24. |
|
Funds Utilization |
The company intends to utilize the proceeds from the IPO to repay borrowings and for general corporate purposes. |
|
IPO Performance |
The Rs 300 Crore IPO consists of a fresh issue of 0.75 crore shares and an offer to sell up to 6.78 crore equity shares. The Shares made a muted debut on the stock market as the hospital chain was listed at a mild discount of 1.27 per cent at Rs 396.90 on BSE, against the issue price of Rs 402. However, the stock kicked off its maiden trading session at par that is the issue price itself. The issue was overall subscribed by 1.55 times. |
Funds Mobilization by Corporates (Rs. In Crore)
|
Particulars |
Dec-25 |
Jan-25 |
|
I. Equity Issues |
71,360 |
13,652 |
|
a. IPOs (i+ii) |
27,031 |
3,066 |
|
i. Main Board |
26,025 |
2,078 |
|
ii. SME Platform |
1,006 |
987 |
|
b. FPOs |
0 |
0 |
|
c. Equity Rights Issues |
4,088 |
507 |
|
d. QIPs/IPPs |
34,739 |
3,961 |
|
e. Preferential Allotments |
5,502 |
6,119 |
|
II. Debt Issues |
1,18,671 |
68,527 |
|
a. Debt Public Issues |
722 |
770 |
|
b. Private Placement of Debt |
1,17,949 |
67,757 |
|
III. REITs/ InvITs |
5,215 |
6,876 |
|
a. REITs |
3,500 |
0 |
|
b. InvITs |
1,715 |
6,876 |
|
Total Funds Mobilized (I+II+III) |
1,95,246 |
89,055 |
Acknowledgements:
RBI Bulletin (www.bulletin.rbi.org.in), SEBI (www.sebi.gov.in), NSE (www.nseindia.com), BSE (www.bseindia.com)
Disclaimer:
This material has been prepared by the personnel in Vora Corporate Finance which is Investment Banking arm of Vora Management Consultancy Private Limited and looks after Mergers & Acquisitions (M&A), Private Equity (PE), Fund Raising, Debt syndication and Valuations and is based out of Ahmedabad, Gujarat, India. Any views or opinions expressed herein are solely that of individual authors and may differ from view of Vora Management Consultancy Private Limited. This material is proprietary to Vora Management Consultancy Private Limited and is for your personal use only. Any distribution, copy, reprints or forward to others is strictly prohibited.
This material captures the information based on information available in the public domain, public announcements and sources believed to be reliable. Analysis contained herein is based on publicly available information and appropriate assumptions. This material is intended merely to highlight market developments and is not intended to be comprehensive and does not constitute strategic, investment, legal or tax advice. In no event Vora Management Consultancy Private Limited be liable for any use by any party or for any decision made or action taken by any party in reliance upon, or for any inaccuracies or errors in, or omissions from, the information contained herein and such information may not be relied upon by you for evaluating any transaction.